Radiopharmaceutical company developing copper-based theranostics for cancer diagnosis and treatment.
Founders
Leila Jaafar(Switzerland · ♀)— A biophysics PhD who spent years building radionuclide-production infrastructure, she founded NUCLIDIUM in 2017 to develop copper-based radiopharmaceuticals that are more scalable and affordable for cancer diagnosis and therapy.
Members see the full profile
Create a free EquityFlow account to see NUCLIDIUM's 1 funding round, 6 investors, 12 similar companies.